Cameron Pitt
Gründer bei Quanta Therapeutics, Inc.
Profil
Cameron Pitt is the founder of Quanta Therapeutics, Inc. founded in 2018, where he holds the title of Director & Chief Business Officer.
In 2018, he also started working at Sofinnova Investments, Inc. as a Principal until 2020.
Dr. Pitt has an undergraduate degree from Stanford University and a doctorate from the University of California.
Aktive Positionen von Cameron Pitt
| Unternehmen | Position | Beginn |
|---|---|---|
Quanta Therapeutics, Inc.
 Quanta Therapeutics, Inc. BiotechnologyHealth Technology Quanta Therapeutics, Inc. develops biotechnologies. The American company was founded in 2018 by Cameron Pitt, Frank McCormick. Perry D. Nisen has been the CEO of the company since 2021. | Gründer | 01.01.2018 |
Ehemalige bekannte Positionen von Cameron Pitt
| Unternehmen | Position | Ende |
|---|---|---|
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Private-Equity-Analyst | 30.04.2020 |
Ausbildung von Cameron Pitt
| University of California | Doctorate Degree |
| Stanford University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Finance |
Quanta Therapeutics, Inc.
Quanta Therapeutics, Inc. BiotechnologyHealth Technology Quanta Therapeutics, Inc. develops biotechnologies. The American company was founded in 2018 by Cameron Pitt, Frank McCormick. Perry D. Nisen has been the CEO of the company since 2021. | Health Technology |
